Average Co-Inventor Count = 4.78
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cephalon, Inc. (15 from 247 patents)
2. Incyte Corporation (6 from 666 patents)
3. Incyte Holdings Corporation (3 from 147 patents)
4. Cancer Research Technology Limited (2 from 262 patents)
5. Pharmacopeia Inc. (1 from 101 patents)
23 patents:
1. 12168660 - Derivatives of an FGFR inhibitor
2. 11472801 - Crystalline forms of a FGFR inhibitor and processes for preparing the same
3. 11407750 - Derivatives of an FGFR inhibitor
4. 10280157 - Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor
5. 9914730 - Azaquinazoline inhibitors of Atypical protein Kinase C
6. 9896446 - Azaquinazoline inhibitors of atypical protein kinase C
7. 9873688 - Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor
8. 9321755 - Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor
9. 8673916 - [object Object]
10. 8586588 - Aryl pyridazinone derivatives and their use as H3 receptor ligands
11. 8513232 - Substituted spirocyclic piperidine derivatives as histamine-3 (H3) receptor ligands
12. 8383813 - Fused pyrrolocarbazoles
13. 8247414 - Pyridizinone derivatives and the use thereof as H3 inhibitors
14. 8207168 - Pyridazinone derivatives
15. 8084472 - Fused pyrrolocarbazoles